Shares of AbbVie Inc. ABBV, -1.37% shed 1.37% to $147.69 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, +0.59% rising 0.59% to 3,959.90 and the Dow Jones Industrial Average DJIA, +0.15% rising 0.15% to 31,874.84. AbbVie Inc. closed $28.22 below its 52-week high ($175.91), which the company reached on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Pfizer Inc. PFE, -1.07% fell 1.07% to $50.82, Eli Lilly & Co. LLY, -1.28% fell 1.28% to $322.03, and AstraZeneca PLC ADR AZN, -3.48% fell 3.48% to $65.79. Trading volume (5.3 M) remained 954,395 below its 50-day average volume of 6.3 M.